NextGen Healthcare - NXGN Stock Forecast, Price & News

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.

Analyst Ratings Changes

Separately, Guggenheim raised NextGen Healthcare from a "neutral" rating to a "buy" rating and set a $26.00 price objective on the stock in a report on Friday, May 6th.

NextGen Healthcare Stock Performance

Shares of NASDAQ:NXGN traded down $0.20 during trading on Monday, reaching $17.29. The stock had a trading volume of 296,432 shares, compared to its average volume of 383,011. The business has a fifty day moving average price of $17.58 and a 200-day moving average price of $18.90. The stock has a market cap of $1.18 billion, a PE ratio of 1,750.75 and a beta of 1.07. NextGen Healthcare has a 1-year low of $13.64 and a 1-year high of $21.87.

NextGen Healthcare (NASDAQ:NXGN - Get Rating) last issued its quarterly earnings results on Tuesday, May 17th. The company reported $0.10 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.10. NextGen Healthcare had a positive return on equity of 8.20% and a negative net margin of 0.01%. The firm had revenue of $151.26 million for the quarter, compared to analyst estimates of $150.07 million. During the same period in the previous year, the company posted $0.13 earnings per share. The business's revenue was up 4.9% on a year-over-year basis. Sell-side analysts expect that NextGen Healthcare will post 0.62 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Craig A. Barbarosh sold 3,500 shares of NextGen Healthcare stock in a transaction that occurred on Friday, July 1st. The stock was sold at an average price of $17.39, for a total transaction of $60,865.00. Following the transaction, the director now owns 64,183 shares in the company, valued at $1,116,142.37. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Over the last 90 days, insiders have sold 10,500 shares of company stock worth $185,185. 4.50% of the stock is owned by corporate insiders.